Age-related prevalence of cardiac valvular abnormalities warranting infectious endocarditis prophylaxis

American Journal of Cardiology

Volumn 94, Issue 3, 2004, Pages 386-389

  Croft, Lori B ^a,b   Donnino, Robert ^a   Shapiro, Robert ^a   Indes, Jodi ^a   Fayngersh, Alla ^a   Squire, Anthony ^a   Goldman, Martin E ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; AGING; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COHORT STUDIES; COMORBIDITY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES;

EID: 3242687239     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.04.045     Document Type: Article

References (13)

1. Griffin M.R., Wilson W.R., Edwards W.D., O'Fallon W.M., Kurland L.T. Infective endocarditis Olmstead County, Minnesota, 1950 through 1981. JAMA. 254:1985;1199
2. Durack D.T. Prevention of infective endocarditis. N Engl J Med. 332:1995;38-44
3. Dajani A.S., Taubert K.A., Wilson W., Bolger A.F., Bayer A., Ferrieri P., Gewitz M.H., Shulman S.T., Nouri S., Newburger J.W., et al. Prevention of bacterial endocarditis. Circulation. 96:1997;358-366
4. Bowen R, Glicklich A, Khan M, Rasmussen S, Wadden T, Bilstad J, Graham D, Green L, Lumpkin M, O'Neill R, et al. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: US Department of Health and Human Services interim public health recommendations. Morb Mortal Wkly Rep 1997;46:1061-1066
5. Singh J.P., Evans J.C., Levy D., Larson M., Freed L., Fuller D., Lehman B., Benjamin E.J. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study). Am J Cardiol. 83:1999;897-902
6. Seto T.B., Kwiat D., Taira D., Douglas P., Manning W.J. Physicians' recommen-dations to patients for use of antibiotic prophylaxis to prevent endocarditis. JAMA. 284:2000;68-71
7. Helmcke F., Nanda N.C., Hsiung M.C., Soto B., Adey C.K., Goyal R.G., Gatewood R.P. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1:1987;176-183
8. Perry G.J., Helmcke F., Nanda N.C., Byard C., Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol. 9:1987;952-959
9. Otto C.M. Valvular stenosis: diagnosis, quantitation, and clinical approach. Otto C.M. Textbook of Clinical Echocardiography. 2000;229-264 WB Saunders, Philadelphia, PA
10. Rimington H. Echocardiography: A Practical Guide for Reporting. 1998;The Parthenon Publishing Group, New York, NY
11. Akasaka T., Yoshikawa J., Yoshida K., Okumachi F., Koizumi K., Shiratori K., Takao S., Shakudo M., Kato H. Age-related valvular regurgitation a study by pulsed Doppler echocardiography. Circulation. 76:1987;262-265
12. Klein A., Burstow D., Tajik A., Zachariah P.K., Taliercio C.P., Taylor C.L. Age-related prevalence of valvular regurgitation in normal subjects a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr. 3:1990;54-63
13. US Bureau of the Census. Population Division. Summary of Reportable Diseases and Conditions. 1999:2001;20:2-3